The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cemiplimab in locally advanced and/or metastatic secondary angiosarcomas (CEMangio): A phase II clinical trial.
 
Stefan van Ravensteijn
No Relationships to Disclose
 
Jacco J. De Haan
No Relationships to Disclose
 
Hans Gelderblom
Research Funding - AmMax Bio (Inst); Deciphera (Inst); Ipsen (Inst); Novartis (Inst)
 
Melissa H.S. Hillebrandt-Roeffen
No Relationships to Disclose
 
Richarda M. de Voer
No Relationships to Disclose
 
Frank M. Speetjens
No Relationships to Disclose
 
Suzanne E.J. Kaal
No Relationships to Disclose
 
Minke Smits
No Relationships to Disclose
 
Carla M.L.- van Herpen
No Relationships to Disclose
 
Yvonne M.H. Versleijen-Jonkers
No Relationships to Disclose
 
Ingrid M.E. Desar
No Relationships to Disclose